RxDoctor Payments Data

Sibi Krishnamurthy

Interventional Cardiology · la Jolla, CANPI 1043672181

Payments from drug & device makers

$23,282in general payments, 2019–2025

Across 287 payments — averaging $81.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Edwards Lifesciences$4K
  • Boston Scientific$4K
  • Shockwave Medical, Inc$3K
  • Medtronic$3K
  • Abbott$2K
  • Biotronik Inc.$1K
  • plus $6K from 26 others

What the payments were for

  • Consulting fees$5302%
  • Grants$4722%
  • Travel & lodging$4,01617%
  • Food & beverage$18,04177%
  • Education$1491%
  • Gifts$750%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$23,282 in reported general payments places this provider in the 65th percentile of 585 interventional cardiology providers in California.

See all interventional cardiology providers in California

Medicare billing

Part B allowed, 2024
$120,511
Medicare patients
223
Services billed
590

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
ClopidogrelClopidogrel Bisulfate74$514

Paid to pharmacies, not to this prescriber.

Other interventional cardiology in la Jolla

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →